BioSpace News Archive

INFINITY ANGIOPLASTY BALLOON CO. announced that its innovative balloon platform – INFINITY ANGIOPLASTY BALLOON CATHETER™ has been cleared by the FDA for PTA treatment of peripheral arterial disease, in peripheral vasculature including iliac, femoral, popliteal, infra-popliteal arteries and for the treatment of AV dialysis fistulae.

Problematic substance use has devastating impacts on people, families and communities across Canada.

Lung cancer patients face challenges during pandemic, American Lung Association unites nation in support of those facing lung cancer

- Data showed approximately 1 in 3 people diagnosed with migraine take a recommended acute prescription medication for a migraine attack, while less than 1 in 5 who suffer frequent migraine attacks take a recommended preventive prescription medication - OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine) aims to further understand the burden, stigma and barriers faced by people living with migraine

Two global leaders are expanding their longtime collaborative partnership by launching a new biological wax moth control product that helps safeguard the health of honeybees. Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, and Vita Bee Health, the world’s largest dedicated supplier of honeybee health products, have joined together to develo

NantHealth Announces Eviti Product Updates to Aid Efficiency and Reporting for Payers & NaviNet Product Updates to Enhance the User Experience

The U.S. Food and Drug Administration has issued warning letters to four companies for selling unapproved injectable drug products labeled as homeopathic that can pose serious risks to patient health and violate federal law, as part of

OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of Directors.

Trinity Life Sciences, a leader in global life sciences solutions, introduces a new turnkey stakeholder insight research tool that evaluates the impact of COVID-19 on patient management and load, prescribing and compliance behaviors and sales detailing relative to pre-COVID times

Case Medical today announced that it was awarded U.S. patent number 10,699,513 B2, by the U.S. Patent and Trademark office for “compositions and methods for handling potential prion contamination.”